Ruth Krestin

Ruth Krestin is the VP of Portfolio Strategy at Tissium. Ruth has over 11 years of experience in the pharma industry. After starting her career in strategy consulting at PwC, Ruth most recently spent 6 years at AstraZeneca, holding roles of increasing responsibility in both R&D and commercial, including portfolio management, business insights, and competitive intelligence. Ruth holds an MSc in Technology Policy from MIT and a BSc in Life Science from University College Utrecht.